After conquering US meatless market with GMO plant-based meat line, Impossible Burger sets sights on Britain

Credit: Lakota Gambill
Credit: Lakota Gambill

The American maker of a “bleeding” meat-free burger is planning to launch in Britain after applying for regulatory approval to sell the product.

Impossible Foods hopes to hit British supermarket shelves “sooner rather than later” after Boris Johnson pledged to ensure that the country’s post-Brexit food standards would be governed by science.

Unlike other plant-based food manufacturers, the Silicon Valley startup uses an ingredient produced by a genetically engineered yeast to make its burgers seem more like meat.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

Food regulators in the United States have approved the use of soy leghemoglobin, known as heme, as a colour additive. Impossible lodged a similar application with European authorities two years ago that has yet to be authorised.

Once Britain formally left the European Union, the company filed a separate application with its Food Standards Agency. Dana Wagner, chief legal officer at Impossible, said: 

“The UK has said a lot of very positive things about being open for business, about wanting to be an innovation powerhouse, about being aware of climate change issues and wanting to lead on that.”

This is an excerpt. Read the original post here.

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Jun-19-2026-04_11_20-PM
Daubert for Dummies—Scientific Reliability in U.S. Courts: Daubert, Rule 702, and Made-for-Litigation Evidence
ChatGPT-Image-Jun-22-2026-09_19_55-PM
The challenge of responding to a measles outbreak in a vaccine-skeptical community
ChatGPT-Image-Jun-3-2026-04_29_13-PM
Viewpoint: While unvaccinated children are dying overseas, Congress challenges Trump and Kennedy’s block on aid
Screenshot-2026-06-22-at-9.04.46-PM
Kennedy’s nutrition prescription for medical schools: Real problem, bad cure
Screenshot-2026-06-19-at-4.32.55-PM
Treat measles with cod liver oil and vitamin A? RFK, Jr.’s recommendation has led to a surge in poisonings
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-06-18-at-3.52.25-PM
‘Plasticity’: Can psilocybin support healthy aging by transforming the brains of older adults?
Screenshot-2026-06-22-at-1.42.53-PM
Viewpoint: The booming longevity anti-aging skin care hoax
screenshot pm
Which is better for building healthy farm soil? Organic offers no special edge.
ChatGPT-Image-Jun-21-2026-02_33_08-PM
Texas Air Force base flu outbreak soars to over 220 cases, and one soldier has died after Secretary Hegseth scrapped mandatory military flu shots 
ChatGPT-Image-Jun-9-2026-01_11_37-PM
Turmeric supplements: More risks than benefits
ChatGPT-Image-Jun-15-2026-11_51_00-AM-4
Viewpoint: As the International Association for Research on Cancer loses influence, activists and trial lawyers scramble to protect a lucrative playbook
c-cd-b-fb-b
Trump administration pushes to bring AI “doctors” into U.S. healthcare. The promise — and the risks.
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.